These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17726019)

  • 61. RAGE and S100 protein transcription levels are highly variable in human melanoma tumors and cells.
    Leclerc E; Heizmann CW; Vetter SW
    Gen Physiol Biophys; 2009; 28 Spec No Focus():F65-75. PubMed ID: 20093728
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells.
    Sajithlal G; Huttunen H; Rauvala H; Munch G
    J Biol Chem; 2002 Mar; 277(9):6888-97. PubMed ID: 11739380
    [TBL] [Abstract][Full Text] [Related]  

  • 63. S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha.
    Bianchi R; Giambanco I; Donato R
    Neurobiol Aging; 2010 Apr; 31(4):665-77. PubMed ID: 18599158
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding.
    Sorci G; Riuzzi F; Arcuri C; Giambanco I; Donato R
    Mol Cell Biol; 2004 Jun; 24(11):4880-94. PubMed ID: 15143181
    [TBL] [Abstract][Full Text] [Related]  

  • 65. S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway.
    Zhang L; Liu W; Alizadeh D; Zhao D; Farrukh O; Lin J; Badie SA; Badie B
    Glia; 2011 Mar; 59(3):486-98. PubMed ID: 21264954
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.
    Jensen JL; Indurthi VS; Neau DB; Vetter SW; Colbert CL
    Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1176-83. PubMed ID: 25945582
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
    Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
    [TBL] [Abstract][Full Text] [Related]  

  • 68. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
    Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
    Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathologies involving the S100 proteins and RAGE.
    Heizmann CW; Ackermann GE; Galichet A
    Subcell Biochem; 2007; 45():93-138. PubMed ID: 18193636
    [TBL] [Abstract][Full Text] [Related]  

  • 70. S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.
    Khan MI; Su YK; Zou J; Yang LW; Chou RH; Yu C
    PLoS One; 2018; 13(2):e0190545. PubMed ID: 29444082
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1
    Serrano A; Donno C; Giannetti S; Perić M; Andjus P; D'Ambrosi N; Michetti F
    Mediators Inflamm; 2017; 2017():1626204. PubMed ID: 28713206
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells.
    Tanaka N; Yonekura H; Yamagishi S; Fujimori H; Yamamoto Y; Yamamoto H
    J Biol Chem; 2000 Aug; 275(33):25781-90. PubMed ID: 10829018
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intracellular Protein S-Nitrosylation-A Cells Response to Extracellular S100B and RAGE Receptor.
    Zaręba-Kozioł M; Burdukiewicz M; Wysłouch-Cieszyńska A
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625541
    [TBL] [Abstract][Full Text] [Related]  

  • 74. S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation.
    Arcuri C; Bianchi R; Brozzi F; Donato R
    J Biol Chem; 2005 Feb; 280(6):4402-14. PubMed ID: 15572370
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis.
    Zhou LL; Cao W; Xie C; Tian J; Zhou Z; Zhou Q; Zhu P; Li A; Liu Y; Miyata T; Hou FF; Nie J
    Kidney Int; 2012 Oct; 82(7):759-70. PubMed ID: 22622498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Postoperative impairment of cognitive function in old mice: a possible role for neuroinflammation mediated by HMGB1, S100B, and RAGE.
    Li RL; Zhang ZZ; Peng M; Wu Y; Zhang JJ; Wang CY; Wang YL
    J Surg Res; 2013 Dec; 185(2):815-24. PubMed ID: 23899512
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 78. S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells.
    Seguella L; Capuano R; Pesce M; Annunziata G; Pesce M; de Conno B; Sarnelli G; Aurino L; Esposito G
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31266264
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain.
    Khan MI; Dowarha D; Katte R; Chou RH; Filipek A; Yu C
    PLoS One; 2019; 14(5):e0216427. PubMed ID: 31071146
    [TBL] [Abstract][Full Text] [Related]  

  • 80. S100b treatment overcomes RAGE signaling deficits in myoblasts on advanced glycation end-product cross-linked collagen and promotes myogenic differentiation.
    Olson LC; Nguyen T; Sabalewski EL; Puetzer JL; Schwartz Z; McClure MJ
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1080-C1093. PubMed ID: 38314727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.